• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    D

    Desh Bhagat University

    院校EST. 1972
    742论文总数
    2,326引用总数

    Desh Bhagat University also popularly known as DBU is a private university located in Fatehgarh Sahib district in Punjab.

    论文量&引用量时间轴

    机构学者

    论文(742)

    年份
    起
    –
    止
    排序
    1Nanotechnology-Driven Cancer Therapies for Precision Oncology: Advances and Clinical Outlook
    Vrinda Gupta, Dinesh Kumar, Sonia Gupta, Rajni Tanwar,Nicky Kumar Jaiswal, Md Moidul Islam, Shivani Singh,Neeraj Choudhary, S Gowri,Thomas J Webster, Md Faiyazuddin

    Cancer continues to pose a global health challenge, with conventional therapies often limited by non-specific toxicity, drug resistance, and an inadequate therapeutic index. Nanotechnology offers transformative opportunities by enabling targeted drug delivery, improved pharmacokinetics, and integrated diagnostic-therapeutic platforms (termed nanotheranostics). This review highlights key nanocarrier systems including liposomes, polymeric nanoparticles, dendrimers, inorganic nanostructures, carbon-based materials, extracellular vesicles, and hybrid platforms with a focus on human studies and clinical translation. Design strategies (such as passive and active tumor targeting, biomimicry, and stimuli-responsive release mechanisms) are discussed in the context of improving tumor selectivity and minimizing systemic toxicity. Recent innovations, including AI-supported nanomedicine design, smart nanorobots, and cell-mediated delivery systems, are also examined. Although multiple nano-formulations such as Doxil®, Abraxane®, and Vyxeos® have reached clinical use, challenges remain including large-scale manufacturing, regulatory pathways, long-term safety evaluation, and cost-effective global accessibility. This review provides a critical appraisal of current evidence, translational bottlenecks, and emerging opportunities to guide future nanomedicine development. Nanotechnology is poised to become a cornerstone of precision oncology, enabling personalized, safe, and effective cancer treatment paradigms.

    2026International journal of nanomedicine(2026)引用:6
    引用
    AI阅读
    加入学术空间
    2Designing Last-Mile Trust: Behavioural Nudges and Community Agents for First-Use Intention/Experience
    G Prasanna Kumar

    Introduction: Last-mile adoption of digital finance often stalls at the first transaction because first-time users face uncertainty, cognitive load, and thin interpersonal trust. This study investigates whether behavioural nudges and perceived usefulness, combined with locally credible community agents, convert intention into first use of digital finance. Methods: A community-based field survey (n = 250) was used for the data collection using a structured Likert-scale questionnaire measured on a 5-point scale. The participants were recruited using a random sampling approach, and the z-probability formula was applied to calculate the adequate sample size. The direct effects and moderating effects were analysed using PLS-SEM on SmartPLS. Results/Findings: The findings of the study indicated the positive and statistically significant effect (β = 0.198, p = 0.010) of Behavioural Nudges, which implies that prompts that increase salience and simplified prompts are effective in transforming intention into first digital finance use. The direct effect of Community-Agent Trustworthiness is significant and strongly positive (β = 0.474, p < 0.001). Perceived Usefulness also exhibits a positive and significant direct relationship with first-use intention/experience (β = 0.073, p < 0.001). Community-Agent Trustworthiness plays a significant moderating role between Behavioural Nudges and first-use intention/experience (β = 0.021, p = 0.001). Likewise, Community-Agent Trustworthiness Interaction and Perceived Usefulness (β = 0.002, p = 0.003) have statistically significant results. Conclusion/Implications: The findings suggest that the initial adoption of digital finance does not rely solely on the technological value or behavioural cues, but more importantly on locally based trust-based mechanisms. It is only by reinforcing behavioural nudges and perceived usefulness by trusted community agents that mitigate uncertainty at the point of initial implementation that behavioural nudges are effective. It underscores the importance of adoption policies that combine behavioural design with human relays, and proposes that scalable digital finance projects should focus on trust infrastructures in addition to technological innovation in order to obtain inclusive adoption.

    2026AJBMSS - Advance Journal of Business Management and Social Sciences(2026)引用:4
    引用
    AI阅读
    加入学术空间
    3Sustainable Versus Conventional Approaches: Dual-Doped Α-Fe2o3 Nanoparticles for Enhanced Photocatalytic and Antioxidant Performance
    Pankaj Kumar,Ashwani Tapwal,Ashwani Kumar,Naveen Thakur

    Dye pollutions are persistent organic pollutants that are receiving much attention. Magnetic nanoparticles (NPs) are substantial compounds for the removal of organic dyes from wastewater. In this study, Azadirachta indica (A. indica) extract and polyvinylpyrrolidone (PVP) polymer were used as an encapsulating agent for Ni/Cu-doped α-Fe2O3 NPs. Those NPs exhibit rhombohedral crystals with the crystallite size of 14–22 nm in a spherical shape, which have a saturation magnetization value approximately between 30 and 36 emu·g−1 under ambient conditions. Bismarck brown Y (BBY) and Rhodamine B (RhB) dyes were used to test the photocatalytic activity, and results showed that Fe2O3 had a removal efficiency up to 96

    2026Frontiers of Materials Science(2026)引用:2
    引用
    AI阅读
    加入学术空间
    4Advancing NK Cell Therapies: Expansion and Activation for Next-Generation Immunotherapy
    Dinesh Kumar, Rajni Tanwar

    Natural Killer (NK) cells, a subset of innate lymphoid cells, have emerged as a promising avenue in cancer immunotherapy due to their ability to recognize and eliminate malignant and virusinfected cells without prior antigen sensitization. Unlike T cells, NK cells function independently of Major Histocompatibility Complex (MHC) restriction, making them effective against tumors that evade adaptive immune responses. However, several challenges, including limited persistence, poor tumor infiltration, and immune suppression, hinder their clinical efficacy, particularly in solid tumors. Recent advancements in NK cell expansion, activation, and genetic engineering have significantly enhanced their therapeutic potential. Strategies such as cytokine-mediated stimulation, artificial scaffolds, and CRISPR-based modifications have improved NK cell persistence and cytotoxicity. Additionally, Chimeric Antigen Receptor (CAR)-modified NK cells offer targeted tumor recognition while minimizing the risk of Graft-Versus-Host Disease (GVHD) and Cytokine Release Syndrome (CRS), making them a safer alternative to CAR-T therapy. Despite these advancements, immunosuppressive tumor microenvironments and high manufacturing costs remain key obstacles. Emerging approaches, including metabolic reprogramming, synthetic biology, and combinatorial therapies integrating checkpoint inhibitors and bispecific antibodies, hold promise for overcoming these limitations. Furthermore, the development of off-the-shelf, induced Pluripotent Stem Cell (iPSC)-derived NK therapies is expected to enhance scalability and accessibility. This review highlights the latest progress in NK cell-based immunotherapy, addressing both current challenges and future directions in optimizing NK cell expansion, activation, and genetic engineering for clinical applications.

    2026Current Cancer Therapy Reviews(2026)引用:1
    引用
    AI阅读
    加入学术空间
    5Repurposing Imeglimin for Chemotherapy-Induced Cognitive Impairment: Targeting Mitochondrial Dysfunction and Neuroinflammation.
    Suresh Babu Kondaveeti, Vrinda Gupta, Harpreet Kaur, V. K. Arunprasad, Lakshay kapil, Neeraj Choudhary, Dinesh Kumar

    Chemotherapy-induced cognitive impairment, known as chemo brain, is a severe side effect of cancer treatment that may cause severe memory, attention, executive skills, and cognitive learning damage. There are several underpinning factors of CICI comprising several pathways, such as oxidative stress, impaired mitochondrial function, neural inflammation, insulin resistance, and decreased neurogenesis. Due to its remarkable neuroprotective properties, imeglimin-a new class of antidiabetic medication – looks potentially promising as a treatment method for chemo brain-associated cognitive disorders. Imeglimin affects mitochondrial bioenergetics, playing a role in enhanced mitochondrial O2 uptake, increased membrane potentials and diminished oxidative stress. This is exceptionally important in the chemo brain context, as the chemotherapeutic agents such as cisplatin and doxorubicin commonly cause mitochondrial damage and oxidative stress in neurons of the brain. Also, by functioning as an antioxidant, imeglimin enhances redox homeostasis, thereby protecting against neuronal apoptosis and regular synaptic activity. Neuroinflammation, another significant activity in CICI, is fueled by microglial activation and cytokine production. The anti-inflammatory activity of imeglimin is associated with its ability to suppress NF-κB signaling and reduce the levels of pro-inflammatory cytokine TNF-α and IL-6. Such outcomes suggest that imeglimin might ameliorate the neuroinflammatory responses associated with chemotherapy. In addition, imeglimin enhances insulin sensitivity and modulates brain glucose metabolism, which associates it with the modern concept of chemo brain as “type 3 diabetes”. Enhancing insulin signaling is one of the mechanisms by which imeglimin may increase synaptic plasticity and improve cognitive resilience. Moreover, Imeglimin exhibits multiple mitochondrial and anti-inflammatory actions that may hold potential for mitigating chemobrain-related pathology. However, its therapeutic application in this context remains hypothetical and warrants dedicated preclinical and clinical evaluation. This review discusses these possible mechanisms and emphasises the need for more preclinical and clinical trials to support its role in reducing the cognitive effects of chemotherapy. Unlike prior descriptive chemobrain reviews, this article applies a hypothesis-driven translational framework to critically assess Imeglimin’s mechanistic plausibility, pharmacological constraints, and unmet validation gaps in chemotherapy-induced cognitive impairment. Employing this graphical abstract, here it is shown that Imeglimin mitigatescognitive deficits caused by chemotherapy as it targets oxidative stress,neuroinflammation and mitochondrial dysfunction, positively affectingcognitive functions and neuroprotection

    2026Cellular and Molecular Neurobiology(2026)引用:1
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 742 篇论文

    合作机构(100)

    Punjabi University合作论文 22
    Chitkara University合作论文 22
    昌迪加尔大学合作论文 18
    塔帕尔大学合作论文 15
    Medanta The Medicity合作论文 9
    可爱的专业大学合作论文 6
    Eternal University合作论文 6
    Career Point University合作论文 6
    阿姆利泽纳那克大学合作论文 6
    Dr. Yashwant Singh Parmar University of Horticulture and Forestry合作论文 6

    机构统计